FdaApplication
ANDA 202260
Identifiers
- fda_app_no: ANDA202260
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2013-08-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NORETHINDRONE | NORETHINDRONE | 0.35MG | TABLET;ORAL-28 |
1 product